Governance Incyte Corporation

INCY

US45337C1027

Pharmaceuticals

Market Closed - Nasdaq Other stock markets 01:30:00 21/04/2026 am IST			5-day change	1st Jan Change
96.92 ^USD	-0.92%		+1.43%	-1.87%

17/04	Goldman Sachs Adjusts Incyte Price Target to $100 From $98, Maintains Neutral Rating	MT
14/04	Pharma sector doubles down on AI amid hopes of slashing costs, timelines	RE

Executive Committee: Incyte Corporation

Manager

Positions heldSince

William Meury

58 year

Chief Executive Officer

26/06/2025

Thomas Tray

49 year

Comptroller/Controller/Auditor	-
Director of Finance/CFO	16/09/2025

Michael Morrissey

62 year

Chief Tech/Sci/R&D Officer

01/01/2016

Steven Stein

59 year

Chief Tech/Sci/R&D Officer

02/03/2015

Richard A. Hoffman

64 year

General Counsel

01/12/2025

Pablo Cagnoni

62 year

Chief Tech/Sci/R&D Officer	05/06/2023
President	05/06/2023

Composition of the Board of Directors: Incyte Corporation

Director

CommitteesSince

Julian Baker

59 year

Compensation Committee	26/06/2025
Governance Committee Chair	26/06/2025
Nominating Committee Chair	26/06/2025
Governance Committee	03/06/2025
Nominating Committee	03/06/2025

Jean-Jacques Bienaimé

72 year

Governance Committee	20/01/2015
Nominating Committee	13/05/2020
Compensation Committee Chair
Audit Committee	07/11/2023
Compensation Committee
Governance Committee Chair	15/10/2025
Nominating Committee Chair	15/10/2025

Paul Clancy

64 year

Compensation Committee
Audit Committee Chair	20/01/2015
Finance Committee Chair	20/01/2015
Audit Committee
Governance Committee Chair
Nominating Committee Chair

Jacqualyn Fouse

64 year

Audit Committee	01/07/2025
Finance Committee
Governance Committee	01/07/2025
Nominating Committee	01/07/2025

Otis Brawley

66 year

Governance Committee Chair	01/04/2021
Nominating Committee Chair	01/04/2021
Compensation Committee	17/11/2021

Edmund Harrigan

73 year

Audit Committee
Finance Committee

Katherine High

74 year

Governance Committee	11/06/2019
Nominating Committee	11/06/2019

William Meury

58 year

Director/Board Member

26/06/2025

Latest Appointments: Incyte Corporation

08/04	Palvella Therapeutics, Inc. Appoints Kent Taylor as Senior Vice President of Sales	CI
31/03	Incyte Corporation Announces Resignation of Susanne Schaffert from the Board of Directors, Effective April 15, 2026	CI
26/03	Geron Corporation Announces the Appointment of Patricia S. Andrews and Constantine Chinoporos to Board of Directors	CI
25/03	Incyte Corporation Announces Executive Changes	CI
07/01	Palvella Therapeutics, Inc. Appoints Vimal Patel as Senior Vice President of Medical Affairs	CI
12/12	Incyte Corporation Announces Resignation of Hervé Hoppenot from Board of Directors, Effective December 12, 2025	CI
01/12	Incyte appoints Richard Hoffman as executive vice president and general counsel	RE

More news

Former Officers and Directors: Incyte Corporation

Insider

Positions held

SinceUntil

Paula Swain

Human Resources Officer

01/01/2002

25/08/2025

Wendy Dixon

Director/Board Member	26/05/2010	14/06/2022
Independent Dir/Board Member	27/10/2011	14/06/2022

Paul Friedman

Director/Board Member	01/11/2001	26/05/2021
Chief Executive Officer	01/11/2001	13/11/2014
Independent Dir/Board Member	13/11/2014	26/05/2021
President	01/05/2004	13/11/2014

Paul Brooke

Director/Board Member	01/01/2001	26/05/2020
Independent Dir/Board Member	27/10/2011	26/05/2020

Victor Sandor

Chief Tech/Sci/R&D Officer

01/01/2010

01/09/2019

Robert Newton

Corporate Officer/Principal

01/01/2014

01/01/2019

Reid Huber

Chief Tech/Sci/R&D Officer	01/04/2014	01/12/2018
Corporate Officer/Principal	01/01/2002	01/04/2014

Richard Levy

Chief Tech/Sci/R&D Officer	01/01/2009	30/04/2016
Corporate Officer/Principal	01/08/2003	01/01/2009

James Daly

Corporate Officer/Principal

22/10/2012

26/06/2015

Richard de Schutter

Chairman	01/01/2003	22/05/2015
Independent Dir/Board Member	01/01/2003	22/05/2015

Barry Michael Ariko

Director/Board Member	01/01/2001	-
Independent Dir/Board Member	27/10/2011	-

David Hastings

Director/Board Member	01/10/2003	29/06/2012
Director of Finance/CFO	01/10/2003	31/10/2014

Roy Whitfield

Director/Board Member	01/06/1991	01/11/2001
Chief Executive Officer	01/06/1993	01/11/2001
Chairman	26/11/2001	01/06/2003
Founder	01/04/1991	28/05/2014
Treasurer	01/04/1991	01/06/1991

Patricia Andrews

Corporate Officer/Principal

20/10/2008

29/08/2012

Brian W. Metcalf

Corporate Officer/Principal

01/05/2011

Patricia A. Schreck

General Counsel	01/12/2003	01/01/2011
Corporate Secretary	01/12/2003	01/01/2011

Kim Solomon

Corporate Officer/Principal

01/01/2002

01/01/2011

Eric Siegel

General Counsel	01/10/2010	-
Corporate Secretary	01/08/2011	-

Matthew Emmens

Director/Board Member

01/01/2006

04/02/2009

John Apeler Keller

Corporate Officer/Principal

01/09/2003

12/09/2008

John F. Niblack

Director/Board Member	01/01/2006	-
Independent Dir/Board Member	27/10/2011	-

Scott W. Hurley

Comptroller/Controller/Auditor	-	15/04/2005
Treasurer	-	15/04/2005

Thomas Theriault

Chief Tech/Sci/R&D Officer

01/08/1996

01/04/2004

Richard D. Goold

Corporate Officer/Principal

01/11/2002

01/04/2004

Laurent Chardonnet

Chief Administrative Officer	-	-
Comptroller/Controller/Auditor	01/02/2004	01/06/2015
Treasurer	01/02/2004	01/06/2015

Elias Bendekgey

Director of Finance/CFO	01/01/1998	01/01/2004
General Counsel	01/01/1998	01/01/2004

James P. Merryweather

Corporate Officer/Principal

01/03/1999

01/01/2004

John M. Vuko

Director of Finance/CFO

01/12/1999

01/10/2003

Robert Stein

Chief Tech/Sci/R&D Officer	01/01/2001	01/01/2003
President	01/01/2001	01/01/2003

Wenqing Yao

Corporate Officer/Principal

28/10/2011

Steve Friedman

Chief Tech/Sci/R&D Officer	01/01/2002	02/06/2010
Corporate Officer/Principal	02/06/2010	-

Samuel T. LaBrie

Corporate Officer/Principal

01/01/2001

Tod M. Klingler

Corporate Officer/Principal

Jeffrey C. Collison

Founder

05/07/2011

Arthur Donny Strosberg

Founder

11/10/2010

Changsheng Zheng

Corporate Officer/Principal

Michelle D. Nowicki

Corporate Officer/Principal

Bhavnish Parikh

Corporate Officer/Principal

28/10/2011

Howard Goldstein

Corporate Officer/Principal

Michael Margolis

Corporate Officer/Principal

Victor Tong

Corporate Officer/Principal

Joe Don Heath

Corporate Officer/Principal

David J. Hodgson

Corporate Officer/Principal

Kenny Pollock

Corporate Officer/Principal

Steve Lincoln

Corporate Officer/Principal

16/11/2010

Daniel Maravei

Corporate Officer/Principal

28/10/2011

Sameer Harish

Corporate Officer/Principal

Thomas Tisch

Director/Board Member

Paul Chirico

Public Communications Contact

Eric Lachenmeier

Corporate Officer/Principal

Jon Saxe

Director/Board Member

Pamela M. Murphy

Investor Relations Contact	27/10/2011	-
Public Communications Contact	-	-

Stan N. Stukov

Corporate Officer/Principal

Gregory Fusco

Corporate Officer/Principal

Robert Nail

Corporate Officer/Principal

JoeBen Bevirt

Chief Tech/Sci/R&D Officer

Timothy G. Henn

Comptroller/Controller/Auditor	-	-
Director of Finance/CFO	-	-

C. James Dobbins

Corporate Officer/Principal

David Stanley Bailey

Corporate Officer/Principal

Thiru P. Reddy

Corporate Officer/Principal

Mike Hoerres

Corporate Officer/Principal

Luke I. Chen

Corporate Officer/Principal	17/02/2010	-
President	-	17/02/2010

Angeline K. Shashlo

General Counsel

Laurie King

Human Resources Officer

Sameer Rohatgi

Corporate Officer/Principal

Cate Sabatini

Corporate Officer/Principal

Dewayne McNair

Corporate Officer/Principal

Tim Germann

Corporate Officer/Principal

Aaron D. Solomon

Corporate Officer/Principal

Susan E. Daniels

Corporate Officer/Principal

Ward Davidson

Corporate Officer/Principal

Fiona Ford

Corporate Officer/Principal

18/10/2009

Michael Donovan

Corporate Officer/Principal

Debora W. Tingley

Corporate Officer/Principal

Age distribution of managers

Parity Men Women

Male	16
Female	2

Of which Executive Committee

Male	6
Female	0

Of which Directors

Male	8
Female	0

Revisions

Recommandations analystes

Évolution recommandations analystes 1 an

Évolution recommandations analystes 4 mois

Objectif analystes

Évolution objectif analystes 1 an

Évolution objectif analystes 4 mois

ESG MSCI

Environnement

Social

Gouvernance

Polémique

Controverses Ethiques

Controverses sur les droits de l'Homme

Controverses Subventions fiscales

Conforme à la finance Islamique

Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).

Employees

2,844

Sector

Pharmaceuticals

Calendar

28/04 - Earnings release - Q1 2026

More about the company